| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Nov―27 |
Single-molecule force stability of the SARS-CoV-2-ACE2 interface in variants-of-concern |
Magnus S. Bauer, Sophia Gruber, Adina Hausch, Marcelo C. R. Melo, Priscila S. F. C. Gomes, Thomas Nicolaus, et al. (+4) Lukas F. Milles, Hermann E. Gaub, Rafael C. Bernardi, Jan Lipfert |
| 2 |
[GO] |
2023―Jun―26 |
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines |
Xuexiang Han, Mohamad-Gabriel Alameh, Kamila Butowska, James J. Knox, Kendall Lundgreen, Majed Ghattas, et al. (+10) Ningqiang Gong, Lulu Xue, Ying Xu, Marc Lavertu, Paul Bates, Junchao Xu, Guangjun Nie, Yi Zhong, Drew Weissman, Michael J. Mitchell |
| 3 |
[GO] |
2022―Dec―19 |
The potential impact of nanomedicine on COVID-19-induced thrombosis |
Peije Russell, Lars Esser, Christoph E. Hagemeyer, Nicolas H. Voelcker |
| 4 |
[GO] |
2022―Aug―22 |
A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination |
Guofang Zhang, Yalin Cong, Feng-Liang Liu, Jiufeng Sun, Jiantian Zhang, Guoli Cao, et al. (+32) Lingqiang Zhou, Wenjie Yang, Qingle Song, Fangjun Wang, Ke Liu, Jing Qu, Jing Wang, Min He, Shun Feng, Didar Baimanov, Wei Xu, Rong-Hua Luo, Xin-Yan Long, Shumin Liao, Yunping Fan, Yu-Feng Li, Bai Li, Ximing Shao, Guocheng Wang, Lijing Fang, Huaiyu Wang, Xue-Feng Yu, Yan-Zhong Chang, Yuliang Zhao, Liang Li, Peng Yu, Yong-Tang Zheng, Diana Boraschi, Hongchang Li, Chunying Chen, Liming Wang, Yang Li |
| 5 |
[GO] |
2022―Aug―18 |
Nanotechnology-based strategies against SARS-CoV-2 variants |
Xiangang Huang, Edo Kon, Xuexiang Han, Xingcai Zhang, Na Kong, Michael J. Mitchell, et al. (+2) Dan Peer, Wei Tao |
| 6 |
[GO] |
2022―Jul―25 |
Multiplexed reverse-transcriptase quantitative polymerase chain reaction using plasmonic nanoparticles for point-of-care COVID-19 diagnosis |
Nicole R. Blumenfeld, Michael Anne E. Bolene, Martin Jaspan, Abigail G. Ayers, Sabin Zarrandikoetxea, Juliet Freudman, et al. (+16) Nikhil Shah, Angela M. Tolwani, Yuhang Hu, Terry L. Chern, James Rogot, Vira Behnam, Aditya Sekhar, Xinyi Liu, Bulent Onalir, Robert Kasumi, Abdoulaye Sanogo, Kelia Human, Kasey Murakami, Goutham S. Totapally, Mark Fasciano, Samuel K. Sia |
| 7 |
[GO] |
2022―Jun―16 |
Characterization of nanoparticles-based vaccines for COVID-19 |
Giuditta Guerrini, Davide Magrì, Sabrina Gioria, Donata Medaglini, Luigi Calzolai |
| 8 |
[GO] |
2022―May―12 |
Author Correction: Reasons for success and lessons learnt from nanoscale vaccines against COVID-19 |
Thomas Kisby, Açelya Yilmazer, Kostas Kostarelos |
| 9 |
[GO] |
2022―Apr―07 |
Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines |
Janos Szebeni, Gert Storm, Julia Y. Ljubimova, Mariana Castells, Elizabeth J. Phillips, Keren Turjeman, et al. (+3) Yechezkel Barenholz, Daan J. A. Crommelin, Marina A. Dobrovolskaia |
| 10 |
[GO] |
2021―Nov―04 |
The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines |
P. Bigini, M. Gobbi, M. Bonati, A. Clavenna, M. Zucchetti, S. Garattini, G. Pasut |
| 11 |
[GO] |
2021―Aug―11 |
Reasons for success and lessons learnt from nanoscale vaccines against COVID-19 |
Thomas Kisby, Açelya Yilmazer, Kostas Kostarelos |
| 12 |
[GO] |
2021―Jul―22 |
Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma |
Bo Ning, Zhen Huang, Brady M. Youngquist, John W. Scott, Alex Niu, Christine M. Bojanowski, et al. (+9) Kevin J. Zwezdaryk, Nakhle S. Saba, Jia Fan, Xiao-Ming Yin, Jing Cao, Christopher J. Lyon, Chen-zhong Li, Chad J. Roy, Tony Y. Hu |
| 13 |
[GO] |
2021―Jun―17 |
Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19 |
Zhenhua Li, Zhenzhen Wang, Phuong-Uyen C. Dinh, Dashuai Zhu, Kristen D. Popowski, Halle Lutz, et al. (+8) Shiqi Hu, Mark G. Lewis, Anthony Cook, Hanne Andersen, Jack Greenhouse, Laurent Pessaint, Leonard J. Lobo, Ke Cheng |
| 14 |
[GO] |
2021―Apr―14 |
COVID-19 may become nanomedicine’s finest hour yet |
Steffi Friedrichs, Diana M. Bowman |
| 15 |
[GO] |
2020―Nov―27 |
Nanomedicine and the COVID-19 vaccines |
|
| 16 |
[GO] |
2020―Aug―06 |
Nanotechnology versus coronavirus |
|
| 17 |
[GO] |
2020―Aug―03 |
Dexamethasone nanomedicines for COVID-19 |
Twan Lammers, Alexandros Marios Sofias, Roy van der Meel, Raymond Schiffelers, Gert Storm, Frank Tacke, et al. (+4) Steffen Koschmieder, Tim H. Brümmendorf, Fabian Kiessling, Josbert M. Metselaar |
| 18 |
[GO] |
2020―Jul―29 |
Nanotechnology-based disinfectants and sensors for SARS-CoV-2 |
Sepehr Talebian, Gordon G. Wallace, Avi Schroeder, Francesco Stellacci, João Conde |
| 19 |
[GO] |
2020―Jul―15 |
COVID-19 vaccine development and a potential nanomaterial path forward |
Matthew D. Shin, Sourabh Shukla, Young Hun Chung, Veronique Beiss, Soo Khim Chan, Oscar A. Ortega-Rivera, et al. (+5) David M. Wirth, Angela Chen, Markus Sack, Jonathan K. Pokorski, Nicole F. Steinmetz |
| 20 |
[GO] |
2020―Jul―13 |
Immune-mediated approaches against COVID-19 |
Helena F. Florindo, Ron Kleiner, Daniella Vaskovich-Koubi, Rita C. Acúrcio, Barbara Carreira, Eilam Yeini, et al. (+3) Galia Tiram, Yulia Liubomirski, Ronit Satchi-Fainaro |
| 21 |
[GO] |
2020―Apr―27 |
Nanoscale nights of COVID-19 |
Kostas Kostarelos |
| 22 |
[GO] |
2020―Apr―17 |
The race against COVID-19 |
|
| 23 |
[GO] |
2020―Mar―23 |
Insights from nanomedicine into chloroquine efficacy against COVID-19 |
Tony Y. Hu, Matthew Frieman, Joy Wolfram |
|
